https://allsci.com/news/venture-financing/ratio-therapeutics-series-c-funding-raises-usd/ AllScien 2026-08-03T12:37:25.191866Z Ratio Therapeutics raises USD 70m Series C with Eli Lilly as new strategic investor https://allsci.com/news/debt-financing/annexon-credit-facility-funding-secures-usd-200m/ AllScien 2026-08-03T12:25:53.814058Z Annexon secures USD 200m credit facility as late-stage programs approach market approvals https://allsci.com/news/clinical-trials/bristol-myers-squibb-pipeline-delays-milvexian/ AllScien 2026-08-03T12:16:14.082444Z BMS Q2'26: Milvexian slips as admilparant becomes the key catalyst https://allsci.com/news/earnings-call-insights/abbvie-q2-earnings-guidance-raises-full-year-on/ AllScien 2026-08-03T11:08:18.630013Z AbbVie Q2'26: Etentamig nears regulatory test while Temab-A broadens oncology ambitions https://allsci.com/news/clinical-trials/sanofi-atopic-dermatitis-halts-asset-despite/ AllScien 2026-08-03T10:57:53.729760Z Sanofi Q2'26: Pipeline review claims amlitelimab as Garijo tightens R&D discipline https://allsci.com/news/pharma/astrazeneca-bristol-myers-merger-and-squibb-held/ AllScien 2026-08-02T20:36:41.916652Z AstraZeneca, Bristol Myers Squibb explored potential merger, Financial Times reports